Identification of Epsin1 as a regulator for hepatic lipid and glucose metabolism

作     者：Xiaohua Huang Long Jin Zhengfeng Fang Lianqiang Che Yan Lin Shengyu Xu Yong Zhuo Mingzhou Li De Wu Bin Feng Xiaohua Huang;Long Jin;Zhengfeng Fang;Lianqiang Che;Yan Lin;Shengyu Xu;Yong Zhuo;Mingzhou Li;De Wu;Bin Feng

作者机构：Animal Nutrition InstituteSichuan Agricultural UniversityChengduSichuan 611130China Key Laboratory of Animal Disease-Resistant Nutrition of Ministry of EducationSichuan Agricultural UniversityChengduSichuan 611130China College of Animal ScienceSichuan Agricultural UniversityChengduSichuan 611130China 

出 版 物：《Genes & Diseases》 (基因与疾病（英文）)

年 卷 期：2023年第10卷第1期

页      面：72-75页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：This study was supported by the National Natural Science Foundation of China(No.31900834) the China's Overseas Expertise Introduction Project for Discipline Innovation("111 Project")(No.D17015) 

主　　题：metabolism healing wound 

摘      要：Obesity related non-alcoholic fatty liver disease(NAFLD),which can progress to steatohepatitis and insulin resistance,has become a major chronic liver disease worldwide.1 As an adaptor of clathrin-mediated endocytosis,Epsin1 plays a role in many diseases,including tumors,atherosclerosis and diabetic wound healing.